Aller au contenu principal
Accès ouvert déclaré 2025 article

Endothelialization of coronary stents after intra-luminal adenoviral VEGF-A gene transfer in a preclinical porcine restenosis model – Studies with optical coherence tomography, angioscopy, multiphoton and scanning electron microscopy

2Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : fi. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

BACKGROUND: Coronary stenting operations have become the main option for the treatment of coronary heart disease. Vessel recovery after stenting has emerged as a critical factor in reducing possible complications. In this study, we evaluated the feasibility, safety and efficacy of locally administered intraluminal gene therapy delivered using a specialized infusion balloon catheter. METHODS: Sixteen pigs received bare metal stents (BMS) in the left circumflex coronary artery and drug-eluting stents (DES) in the right coronary artery. Adenoviral (Ad) gene transfers (dose 1,5e10 pfu) of VEGF-A and LacZ were performed with a ClearWay™ RX infusion balloon catheter on both stents. In vivo imaging included angiography, OCT and angioscopy. Tissue samples were collected for analyses at day 14 and studied using scanning electron microscopy and multiphoton microscopy. RESULTS: AdVEGF-A accelerated re-endothelialization in the BMS compared to the other groups. The highest restenosis was in the BMS AdLacZ group. DES groups had statistically significant reduced maximum stenosis compared to BMS AdLacZ. No major in-stent thrombosis events were detected. Ex vivo imaging showed that intraarterial imaging is not very accurate in the detection of endothelial layer. Biodistribution of the Ad vector and measured safety parameters (off-target tissues and blood tests) did not show any major safety concerns. CONCLUSION: Adenoviral gene transfer using the ClearWay™ RX catheter was feasible and safe. AdVEGF-A accelerated re-endothelization in BMS. However, DES showed better outcomes in the short-term regarding restenosis and do not benefit from intraluminal AdVEGF-A gene transfer.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Endothelialization of coronary stents after intra-luminal adenoviral VEGF-A gene transfer in a preclinical porcine restenosis model – Studies with optical coherence tomography, angioscopy, multiphoton and scanning electron microscopy
Date Crossref
01/02/2025
Éditeur
Elsevier BV
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Coronary Interventions and DiagnosticsVirus-based gene therapy researchAngiogenesis and VEGF in Cancer

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.